FlyBase curator comment: this entry represents a transgenic construct where the particular construct used cannot be determined.
FlyBase curator comment: "Parkinson's disease 1" is associated with mutations in human SNCA.
Expressing Hsap\SNCAUAS.cUa under the control of Scer\GAL4ple.PF induces a progressive decrease in adult climbing capacity and results in 21-days old adults raised at 29[o]C exhibiting significantly fewer PPL1 neurons than age-matched controls; there is no obvious effect on lifespan.
Expression of Hsap\SNCAScer\UAS.cUa under the control of Scer\GAL4ple.PU does not lead to any significant decrease in the number of dopaminergic neurons from the PPM1/2 cluster in young (3 and 10 days old) adult flies.
Expression of Hsap\SNCAScer\UAS.cUa under the control of Scer\GAL4ple.PU results in reduction of PPL1 dopaminergic neuron number, as compared with controls.
Expression of Hsap\SNCAScer\UAS.cUa leads to reduced climbing ability (with either the Scer\GAL4elav.PU or the Scer\GAL4Ddc.PU driver) and loss of dopaminergic neurons (using the Scer\GAL4Ddc.PU driver) in aged adult flies.
The lifespan of flies expressing Scer\GAL4elav.PU>Hsap\SNCAScer\UAS.cUa is shorter than that of wild-type.
Aging flies expressing Scer\GAL4elav.PU>Hsap\SNCAScer\UAS.cUa show impaired climbing ability and the progressive loss of dorsomedial dopaminergic neurons.
Ectopic expression of Hsap\SNCAScer\UAS.cUa under the control of either Scer\GAL4C164 or Scer\GAL4ple.PF results in defects in locomotion and a significant decrease in the distance crawled by third instar larvae per unit of time compared to controls.
Ectopic expression of Hsap\SNCAScer\UAS.cUa under the control of either Scer\GAL4elav.PU results in defects in negative geotaxis and significantly reduces climbing activity of adult flies compared to controls.
Hsap\SNCAUAS.cUa, Scer\GAL4elav.PU has short lived phenotype, enhanceable by Lk6UAS.cUa, Scer\GAL4elav.PU
Hsap\SNCAUAS.cUa, Scer\GAL4elav.PU has abnormal neuroanatomy | progressive phenotype, enhanceable by Lk6UAS.cUa, Scer\GAL4elav.PU
Hsap\SNCAUAS.cUa, Scer\GAL4elav.PU has abnormal locomotor behavior | adult stage | progressive phenotype, enhanceable by Lk6UAS.cUa, Scer\GAL4elav.PU
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PF has decreased cell number | adult stage phenotype, suppressible by stUAS.Venus, Scer\GAL4ple.PF
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PF has abnormal locomotor behavior | adult stage | progressive phenotype, suppressible by stUAS.Venus, Scer\GAL4ple.PF
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU has abnormal neuroanatomy | adult stage phenotype, suppressible by comtUAS.cGa, Scer\GAL4ple.PU
Hsap\SNCAUAS.cUa, Scer\GAL4C164 has abnormal locomotor behavior | third instar larval stage phenotype, suppressible by Rab8UASp.YFP, Scer\GAL4C164
Hsap\SNCAUAS.cUa, Scer\GAL4elav.PU has abnormal locomotor behavior | adult stage phenotype, suppressible by Rab8UASp.YFP, Scer\GAL4elav.PU
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PF has abnormal locomotor behavior | third instar larval stage phenotype, suppressible by Rab8UASp.YFP, Scer\GAL4ple.PF
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxGD7187 has abnormal neuroanatomy | adult stage phenotype
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxGD7187 has decreased cell number | adult stage phenotype
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxKK100927 has abnormal neuroanatomy | adult stage phenotype
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxKK100927 has decreased cell number | adult stage phenotype
Hsap\SNCAUAS.cUa, Scer\GAL4elav.PU has dopaminergic neuron | progressive phenotype, enhanceable by Lk6UAS.cUa, Scer\GAL4elav.PU
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PF has dopaminergic PPL1 neuron phenotype, suppressible by stUAS.Venus, Scer\GAL4ple.PF
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU has dopaminergic PPL1 neuron phenotype, suppressible by comtUAS.cGa, Scer\GAL4ple.PU
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxGD7187 has dopaminergic PPM2 neuron | adult stage phenotype
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxGD7187 has dopaminergic PPM1 neuron | adult stage phenotype
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxKK100927 has dopaminergic PPM2 neuron | adult stage phenotype
Hsap\SNCAUAS.cUa, Scer\GAL4ple.PU, auxKK100927 has dopaminergic PPM1 neuron | adult stage phenotype
Co-expression of Hsap\SNCAScer\UAS.cUa with either auxGD7187 or auxKK100927 leads to significant decrease in the number of dopaminergic PPM1/2 neurons in the brains of young (3 and/or 10 days old) adult flies, which is not observed at this age when either of the transgenes is expressed alone.
Co-expression of comtScer\UAS.cGa rescues the PPL1 dopaminergic neuron loss phenotype of flies expressing Hsap\SNCAScer\UAS.cUa under the control of Scer\GAL4ple.PU.
The locomotion defects characteristic for third instar larvae expressing Hsap\SNCAScer\UAS.cUa under the control of either Scer\GAL4C164 or Scer\GAL4ple.PF can be suppressed by co-expression of Rab8Scer\UAS.P\T.T:Avic\GFP-YFP : the decrease in the distance crawled by third instar larvae per unit of time is significantly ameliorated.
The negative geotaxis defects characteristic for flies expressing Hsap\SNCAScer\UAS.cUa under the control of either Scer\GAL4elav.PU can be suppressed by co-expression of Rab8Scer\UAS.P\T.T:Avic\GFP-YFP : the reduction in climbing activity of adult flies is significantly ameliorated.